Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / FBLN1

FBLN1

Basics

Aliases:
This biomarker is also known as:
  • FIBL-1,
  • Fibulin-1,
  • FBLN,
  • fibulin 1,

View in BioMuta

Description…

Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. FBLN1 may play a role in cell adhesion and migration along protein fibers within the extracellular matrix. It could be important for certain developmental processes and contribute to the supramolecular organization of extracellular matrix architecture, in particular to those of basement membranes. It has been implicated in a role in cellular transformation and tumor invasion, and it appears to be a tumor suppressor. It may also play a role in haemostasis and thrombosis owing to its ability to bind fibrinogen and incorporate into clots. FBLN1 could play a significant role in modulating the neurotrophic activities of APP, particularly soluble APP. FBLN1 is widely expressed during embryonic development.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: FBLN1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement